This paper reports the design, synthesis, in vitro and in vivo evaluation of TF-8arm-PEG-DHA NPs with TF as the targeting ligand to enhance the cellular uptake and anti-cancer activity through receptor-mediated endocytosis between TF and TFR. Here, TF is linked to cancer.